Insider Transactions Reported by 8 Insiders of CHAMPIONS ONCOLOGY, INC.

Symbol
CSBR on Nasdaq
Location
Baltimore, MD

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

CHAMPIONS ONCOLOGY, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert L. Brainin CEO, Director $6,038,471 16 Jul 2025
Ronnie Morris CEO, Director $5,582,707 17 Mar 2023
Joel Ackerman Director $2,362,999 05 Nov 2025
Brady Davis President $1,368,250 09 Oct 2023
Scott R. Tobin Director, 10%+ Owner $173,128 05 Nov 2025
David Sidransky Director $144,268 05 Nov 2025
Philip P. Breitfeld Director $124,815 05 Nov 2025
Daniel Newman Mendelson Director $93,772 05 Nov 2025

Recent Insider Transactions by Companies or Individuals for CHAMPIONS ONCOLOGY, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Philip P. Breitfeld CSBR Option to purchase Common Stock Award 13,790 13,790 05 Nov 2025 Direct
Daniel Newman Mendelson CSBR Option to purchase Common Stock Award 13,790 13,790 05 Nov 2025 Direct
David Sidransky CSBR Option to purchase Common Stock Award 21,216 21,216 05 Nov 2025 Direct
Joel Ackerman CSBR Option to purchase Common Stock Award 21,216 21,216 05 Nov 2025 Direct
Scott R. Tobin CSBR Option to purchase Common Stock Award 25,460 25,460 05 Nov 2025 Direct
Joel Ackerman CSBR Common Stock Options Exercise 9.81% 94,405 1,056,539 30 Oct 2025 Direct
Joel Ackerman CSBR Option to purchase Common Stock Options Exercise -100% -94,405 0 30 Oct 2025 Direct
Robert L. Brainin CSBR Option to purchase Common Stock Award 943.9% 700,000 774,163 16 Jul 2025 Direct
Philip P. Breitfeld CSBR Common Stock Other -42.1% -4,150 5,717 25 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.